Markets:

Overview

News

Currencies

International

Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

9.170 -0.580 (-5.95%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

65 66 Next >

Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday? ↗

May 10, 2024

A worse-than-expected University of Michigan’s May consumer report halted stock gains on Friday, sparking worries about a potential decline in consumer health amid perceived rising price pressures.

Via Benzinga

Topics Economy

OKLO Stock Alert: 7 Things to Know as Sam Altman-Backed Oklo Starts Trading Today ↗

May 10, 2024

Oklo stock is falling on Friday as the company's shares made their public debut today following a SPAC merger backed by Sam Altman.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 10, 2024

Via Benzinga

How Is The Market Feeling About Novavax? ↗

May 01, 2024

Via Benzinga

Down 60% From Its 52-Week High, Is Novavax Stock a Buy? ↗

April 12, 2024

Is there still too much risk surrounding this business?

Via The Motley Fool

Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 10, 2024

Via Benzinga

Novavax Sheds Going Concern Warning as NVAX Stock Pops on Sanofi Licensing Deal ↗

May 10, 2024

NVAX stock is rising higher after the biotechnology company announced that it had signed a licensing deal with Sanofi.

Via InvestorPlace

Nasdaq Moves Lower; US Consumer Sentiment Falls In May ↗

May 10, 2024

Via Benzinga

NVAX Stock Earnings: Novavax Beats EPS, Misses Revenue for Q1 2024 ↗

May 10, 2024

NVAX stock results show that Novavax beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday ↗

May 10, 2024

Via Benzinga

Dow Jumps Over 100 Points; DNOW Posts Downbeat Earnings ↗

May 10, 2024

Via Benzinga

Topics Stocks

Why Is Progyny (PGNY) Stock Down 27% Today? ↗

May 10, 2024

Progyny stock is down on Friday after the company posted a revenue miss for Q1 and disappointed PGNY investors with its guidance!

Via InvestorPlace

Why Natera Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket ↗

May 10, 2024

Via Benzinga

Why Is Macrogenics (MGNX) Stock Down 69% Today? ↗

May 10, 2024

Macrogenics stock is down on Friday as MGNX investors react to clinical trial deaths and missed earnings for the first quarter of 2024.

Via InvestorPlace

Topics Death

Why Is AEye (LIDR) Stock Up 38% Today? ↗

May 10, 2024

AEye stock is up on Friday after as LIDR shareholders celebrate the company signing a partnership with LiteOn Technology Corporation.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 10, 2024

Via Benzinga

Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases Doubts About Its Going Concern ↗

May 10, 2024

Novavax strikes co-exclusive licensing deal with Sanofi (SNY) for COVID-19 and flu-COVID-19 vaccines. Terms include upfront payment of $500M, milestone opportunities, and revenue guidance update.

Via Benzinga

Why Is Novavax (NVAX) Stock Up 118% Today? ↗

May 10, 2024

Novavax stock is up on Friday after the vaccine company announced a licensing agreement with Sanofi as its Q1 earnings report.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

May 10, 2024

The biggest pre-market stock movers are ready to go as we check out all of the hottest news happening on Friday morning!

Via InvestorPlace

US Stocks Set To End Week Strong With S&P 500 Eyeing Break Above Late-March Peak: Analyst Says He's Still A Buy In May Amid This Positive Signal ↗

May 10, 2024

U.S. stocks are on track to finish the week on a high, with the index futures pointing to a higher opening on Friday.

Via Benzinga

Topics Stocks

Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street Analysts ↗

May 09, 2024

High-water price targets from a trio of Wall Street pundits imply three diminutive companies can skyrocket 223% to 557%.

Via The Motley Fool

Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential' ↗

May 09, 2024

Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists.

Via Benzinga

Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual Meeting

May 06, 2024

From Shah Capital

Via GlobeNewswire

Pfizer Finds a Foothold After a Solid Q1 2024 Earnings Report

May 06, 2024

After a painful two-year selloff, Pfizer shareholders may have finally gained a foothold after the company delivered a solid Q1 2024 earnings report

Via MarketBeat

3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole ↗

April 29, 2024

These stocks aren't bargains.

Via The Motley Fool

3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition ↗

April 25, 2024

Many fortunes have been made with a fortuitous investment in a biotech stock at the right time. That time might be now.

Via InvestorPlace

These Biotech Stocks Could Soar 120% and 295%, According to Wall Street ↗

April 21, 2024

Catalysts lie ahead for both of these companies.

Via The Motley Fool

What's Going On With Novavax Stock Today? ↗

April 15, 2024

In a new regulatory filing, Shah Capital, which owns 9.3 million shares of Novavax representing a 6.66% stake in the company, expressed disappointment with the recent performance of Novavax stock and...

Via Benzinga

Shah Capital nominates two highly qualified independent director candidates for Novavax

April 15, 2024

From Shah Capital

Via GlobeNewswire

Better Buy: Bluebird Bio Vs. Novavax ↗

April 13, 2024

Who wins this face-to-face between two beaten-down biotechs?

Via The Motley Fool

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

65 66 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Novavax, Inc. - Common Stock (NQ:NVAX)

All News about Novavax, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today